UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients

Arthritis care & research (2010), 2010-04, Vol.62 (4), p.569-574

2010

Volltextzugriff (PDF)

The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis

Clinical and experimental rheumatology, 2007-01, Vol.25 (1), p.40

2007

Volltextzugriff (PDF)

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

Osteoporosis international, 2006-11, Vol.17 (11), p.1630-1637

2006

Volltextzugriff (PDF)

SAT0066 BURDEN OF MALIGNANCY, VENOUS THROMBOEMBOLISM, ANEMIA, AND INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO SWITCHED FROM A FIRST CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG TO ANOTHER DISEASE-MODIFYING ANTIRHEUMATIC DRUG REGIMEN

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.966-967

2020

Volltextzugriff (PDF)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

Osteoporosis international, 2021-01, Vol.32 (1), p.55-61

2021

Volltextzugriff (PDF)

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

The journal of clinical endocrinology and metabolism, 2002-10, Vol.87 (10), p.4528-4535

2002

Volltextzugriff (PDF)

Reduced risk of back pain following teriparatide treatment : a meta-analysis

Osteoporosis international, 2006-02, Vol.17 (2), p.273-280

2006

Volltextzugriff (PDF)

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

Annals of the rheumatic diseases, 2010-05, Vol.69 (5), p.872-875

2010

Volltextzugriff (PDF)

AB1143 BURDEN OF GLUCOCORTICOIDS AMONG RHEUMATOID ARTHRITIS PATIENTS AT DIFFERENT STAGES OF DISEASE-MODIFYING ANTIRHEUMATIC DRUG MANAGEMENT

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1861-1862

2020

Volltextzugriff (PDF)

THU0555 HEALTHCARE COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS SWITCHING FROM THEIR FIRST CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG TO ANOTHER DISEASE-MODIFYING ANTIRHEUMATIC DRUG REGIMEN

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.518-519

2020

Volltextzugriff (PDF)

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2018-08, Vol.103 (8), p.2949-2957

2018

Volltextzugriff (PDF)

The gout diagnosis

Cleveland Clinic journal of medicine, 2008-07, Vol.75 (Suppl 5), p.S17-S21

Dore, Robin K

2008

Volltextzugriff (PDF)

Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis

Patient preference and adherence, 2013-01, Vol.7 (default), p.435-446

Dore, Robin K

2013

Volltextzugriff (PDF)

Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed by 24 Months of Alendronate

Journal of clinical densitometry, 2018-10, Vol.21 (4), p.606-607

2018

Volltextzugriff (PDF)

Clinical utility of etanercept in the treatment of arthritides in children and adolescents

Adolescent health, medicine and therapeutics, 2014-01, Vol.5 (default), p.35-48

Dore, Robin K

2014

Volltextzugriff (PDF)

The Present and Future Adequacy of Rheumatology Manpower. A Study of Health Care Needs And Physician Supply

Arthritis and rheumatism, 1991-10, Vol.34 (10), p.1209-1217

1991

Volltextzugriff (PDF)

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

Archives of internal medicine (1960), 2002-06, Vol.162 (11), p.1293

2002

Volltextzugriff (PDF)

Generalized Morphea with Peripheral Eosinophilia, Fasciitis and Myositis

International journal of dermatology, 1980-04, Vol.19 (3), p.149-153

1980

Volltextzugriff (PDF)

The effects of teriparatide on the risk of back pain in men and women with osteoporosis: A meta-analysis

2005

Volltextzugriff (PDF)

Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

2006

Volltextzugriff (PDF)

Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

2005

Volltextzugriff (PDF)

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Nature immunology, 2022-02, Vol.23 (2), p.210-216

2022

Volltextzugriff (PDF)

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

The New England journal of medicine, 2018-01, Vol.378 (4), p.354-369

2018

Volltextzugriff (PDF)

National Diversity and Global Capitalism

1, 2018

Volltextzugriff (PDF)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Journal of hepatology, 2016-07, Vol.65 (1), p.17-25

2016

Volltextzugriff (PDF)

1 – 25 von 741

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(683)
Mit Volltextzugriff
(630)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(456)
Physical Sciences
(237)
Life Sciences & Biomedicine
(216)
Humans
(183)
Physics
(181)
Astronomy & Astrophysics
(157)
Astrophysics
(127)
Male
(105)
Female
(104)
Astronomy And Astrophysics
(97)
Biological And Medical Sciences
(89)
Cosmic Background Radiation
(88)
Sciences Of The Universe
(82)
Adult
(81)
Cosmology: Observations
(76)
Medical Sciences
(72)
Cosmology And Extra-Galactic Astrophysics
(69)
Middle Aged
(64)
Aged
(56)
Cosmic Microwave Background
(54)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients

The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis

Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment : a meta-analysis

SAT0066 BURDEN OF MALIGNANCY, VENOUS THROMBOEMBOLISM, ANEMIA, AND INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO SWITCHED FROM A FIRST CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG TO ANOTHER DISEASE-MODIFYING ANTIRHEUMATIC DRUG REGIMEN

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis

Reduced risk of back pain following teriparatide treatment : a meta-analysis

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

AB1143 BURDEN OF GLUCOCORTICOIDS AMONG RHEUMATOID ARTHRITIS PATIENTS AT DIFFERENT STAGES OF DISEASE-MODIFYING ANTIRHEUMATIC DRUG MANAGEMENT

THU0555 HEALTHCARE COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS SWITCHING FROM THEIR FIRST CONVENTIONAL SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG TO ANOTHER DISEASE-MODIFYING ANTIRHEUMATIC DRUG REGIMEN

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

The gout diagnosis

Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis

Persistent Fracture Reduction with Abaloparatide-SC (TYMLOS™) Followed by 24 Months of Alendronate

Clinical utility of etanercept in the treatment of arthritides in children and adolescents

The Present and Future Adequacy of Rheumatology Manpower. A Study of Health Care Needs And Physician Supply

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial

Generalized Morphea with Peripheral Eosinophilia, Fasciitis and Myositis

The effects of teriparatide on the risk of back pain in men and women with osteoporosis: A meta-analysis

Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

National Diversity and Global Capitalism

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

Suchergebnisse filtern